News Between Reporter

A recent survey conducted by the American Medical Association (AMA) has revealed that half of healthcare organizations surveyed have either eliminated or are actively working to eliminate race-based clinical algorithms and decision-making tools. These tools have historically used race as a proxy for genetic or biological ancestry, which can lead to inaccurate assessments and biased
0 Comments
In a heartbreaking turn of events, life-support treatment has been withdrawn from a critically ill baby girl named Indi Gregory. The eight-month-old has been at the centre of a legal battle between her parents and medical professionals. Despite their efforts, Indi’s parents have failed in their attempts to continue life-sustaining treatment for their daughter. This
0 Comments
Reliance’s Jio AirFiber service has emerged as a game-changer in the Indian broadband market, particularly for those who lack access to fiber broadband in their homes and offices. With its 5G Fixed Wireless Access (FWA) technology, Jio AirFiber aims to bridge the connectivity gap in the country, making high-speed internet more accessible than ever. In
0 Comments
After several months of strike-induced setbacks in the entertainment industry, James Gunn, the famed director, has finally broken his silence and shared updates on the highly anticipated DC film, Superman: Legacy. Despite the extensive Hollywood turmoil caused by the Writers Guild of America (WGA) and the Screen Actors Guild-American Federation of Television and Radio Artists
0 Comments
In the ARIES-HM3 trial, the decision to exclude aspirin from the antithrombotic therapy regimen after HeartMate 3 left ventricular assist device (LVAD) implantation was shown to be a safer approach compared to the usual combination approach. The trial involved comparing the effectiveness of placebo in combination with warfarin or other vitamin K antagonist therapy, to
0 Comments
In a groundbreaking clinical trial conducted by Novo Nordisk, the anti-obesity drug Wegovy has shown significant potential in reducing the risk of serious cardiovascular complications in individuals with obesity and heart disease. The study, known as Select, involved approximately 17,500 participants who did not have diabetes. Detailed results from the trial, presented at the American
0 Comments